Cegedim: 13.2% growth in antidepressant drug sale

If in United States of America the sales of anti-depressant drug sales grew by 15% last year, a similar trend was recorded in Romania, where the increase pace stood at 13.2% in national currency, according to Cegedim research.

“The sale of anti-depressant medicines increased last year below the 17.7% market average. However, it will be interesting to see the see the trend of the segment in the first quarter this year to make an opinion”, Petru Craciun, managing director of Cegedim Romania told Wall-Street.

According to Cegedim research, 94.6% of the antidepressant drugs sold last year in the retail chain were released on prescription.

In USA, the number of prescriptions for sleeping pills increased 7% from a year earlier; however the prescriptions for antidepressants jumped 15%, according to IMS Health research.

Although the majority of companies are experiencing dwindling sales, certain pharmaceutical companies are enjoying major increases in sales of anti-depressant drugs and sleeping pills, in spite of shrinking marketing expenditures.

The investments in advertising in US for sleeping pills fell from 190 mln dollars in 2007, to 150 mln dollars in 2008. Nevertheless, investments in advertising antidepressants remained constant.

Citeste si:

Calculator Salariu: Află câți bani primești în mână în funcție de salariul brut »

Despre autor

Roxana a absolvit Facultatea de Litere , fiind și traducător autorizat de engleză și franceză. Are o experiență de peste 15 ani în presă și comunicare, este grammar nazi și pasionată de istoria artei. Ca jurnalist, a lucrat pentru publicații precum Businessmen's, Bucharest Business Week , România Liberă - unde a fost editor coordonator - și Wall-Street.ro . De-a lungul carierei jurnalistice, Roxana a scris pe domenii precum diplomație , turism , aviație , retail ,...